Abnormalities, Cardiovascular Clinical Trial
— CVMRIOfficial title:
Development of New Software Capabilities for Use With Cardiovascular Magnetic Resonance Imaging
Verified date | May 2017 |
Source | University of California, Davis |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
This Protocol is intended to facilitate development and testing of new cardiovascular MRI software capabilities by UC Davis Research Faculty, as well as to facilitate the evaluation of new software capabilities provided by GE and Siemens.
Status | Terminated |
Enrollment | 42 |
Est. completion date | July 2014 |
Est. primary completion date | July 2014 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - 18 years of age or older - Ability to give informed, written consent - Not Pregnant or breastfeeding Exclusion Criteria: - Electrically, magnetically, or mechanically activated implants (for example, cardiac-pacemakers) - Ferromagnetic implant, such as an aneurysm clip, surgical clip, or prosthesis - History of uncontrolled claustrophobia |
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
University of California, Davis |
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Extend or generalize certain capabilities, such as new data acquisition pulse sequences, new image processing and analysis software for structural and functional analysis of the MR images | Post-scanning | ||
Secondary | Improve image quality by various techniques (e.g. reducing the effects of motion) | Post-scanning |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02910635 -
A Study to Evaluate the Effect of Volanesorsen on Cardiac Repolarization Conducted in Healthy Volunteers
|
Phase 1 |